| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5941895 | Annals of Vascular Surgery | 2015 | 6 Pages |
Abstract
The high sensitivity (100%) and low specificity (22.7%) of MRV suggest that it can be a screening tool at best, used only to rule out PVOO; it cannot be used to confirm PVOO, given its a 41.5% false positive rate. Thus, the development of a different, noninvasive diagnostic test that can more accurately assess patients with suspected PVOO during the initial evaluation of their lower-extremity venous disease should be explored.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Benjamin B. Massenburg, Harvey N. Himel, Robert C. Blue, Michael L. Marin, Peter L. Faries, Windsor Ting,